Concord Biotech has successfully completed the Russian GMP (Good Manufacturing Practice) inspection. The inspection was conducted at company's Active Pharmaceutical Ingredient (API) manufacturing facility located in Dholka, Gujarat. The inspection was conducted from July 22, 2025 to July 25, 2025.
The development highlights company’s commitment to upholding the highest standards of quality, safety, and regulatory compliance across all aspects of the operations.
Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
